Genetic mutations that increase the hetero-dimerisation of FHR5, and thereby increase the ability to compete with FH ligand [32], are strongly associated with a familial C3 glomerulopathy referred to as CFHR5 nephropathy [13]. This evidence concerns the gene CFHR5 and kidney disorder.